C-RAD has been informed that the Chairman of the Board, Lars Nyberg, bought one million C-RAD B shares from the three biggest owners, Per Hamberg, Olle Stenfors and Lars Kling on October 7, 2016. After the transaction he owns 1.250.000 B shares in the company. This transaction is beyond his interest to buy another 600.000 B shares in connection with the Board's decision regarding a private placement of 2 million shares. However, that requires an approval of the majority of the shareholder meeting as communicated earlier.
About C-RAD
C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. Employees currently number 45. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are integrated. C-RAD AB is listed on NASDAQ Stockholm.
For more information on C-RAD, please visit www.c-rad.com
For further information:
Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email investors@c-rad.com
The above information is price-sensitive and must therefore be disclosed under the Securities Market Act (2007:528).
